test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VRDNViridian Therapeutics Inc
Recent Activity
Increased 18373.93%
2.23%
$15.924M↑ Call
699,977 shares@ $22.76 avg price
IMVTImmunovant Inc
Recent Activity
Increased 79.91%
1.99%
$14.255M↑ Call
500,000 shares@ $28.51 avg price
CAPRCapricor Therapeutics Inc
Recent Activity
New Position
1.91%
$13.689M↓ Put
900,000 shares@ $15.21 avg price
RCUSArcus Biosciences Inc
Recent Activity
Increased 491.52%
1.83%
$13.114M↑ Call
857,700 shares@ $15.29 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Increased 102.12%
1.8%
$12.906M↓ Put
625,615 shares@ $20.63 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
Decreased -14.83%
1.78%
$12.759M
499,566 shares@ $25.54 avg price
CYTKCytokinetics Inc
Recent Activity
Increased 30.74%
1.64%
$11.745M↑ Call
222,447 shares@ $52.8 avg price
INSMInsmed Inc
Recent Activity
Increased 188.8%
1.58%
$11.303M
154,835 shares@ $73.0 avg price
NMRANeumora Therapeutics Inc.
Recent Activity
New Position
1.48%
$10.568M↓ Put
800,000 shares@ $13.21 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
New Position
1.41%
$10.094M↓ Put
350,000 shares@ $28.84 avg price